CCN1C(NCC2CC2)=N[C@@H](c2ccccc2)[C@H](C(=O)OC)[C@H]1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?